{"id":"https://openalex.org/W2182663471","doi":null,"title":"Low dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes.","display_name":"Low dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes.","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2182663471","mag":"2182663471","pmid":"https://pubmed.ncbi.nlm.nih.gov/16358997"},"language":"en","primary_location":{"id":"pmid:16358997","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16358997","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111985716","display_name":"Agnieszka M. Kukli\u0144ska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146122375","display_name":"Medical University of Bia\u0142ystok","ror":"https://ror.org/00y4ya841","country_code":"PL","type":"education","lineage":["https://openalex.org/I146122375"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"A M Kukli\u0144ska","raw_affiliation_strings":["Department of Cardiology, Medical University of Bia\u0142ystok, Poland. kuklinska@poczta.onet.pl","Department of Cardiology; Medical University of Bialystok; Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Medical University of Bia\u0142ystok, Poland. kuklinska@poczta.onet.pl","institution_ids":["https://openalex.org/I146122375"]},{"raw_affiliation_string":"Department of Cardiology; Medical University of Bialystok; Poland","institution_ids":["https://openalex.org/I146122375"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023102340","display_name":"Musia\u0142 Wj","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W J Musia\u0142","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017934018","display_name":"K A Kami\u0144ski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K A Kami\u0144ski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027296270","display_name":"Pawe\u0142 Kralisz","orcid":"https://orcid.org/0000-0002-6757-2228","observed_orcids":["https://orcid.org/0000-0002-6757-2228"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Kralisz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071853157","display_name":"Wojciech Modrzejewski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Modrzejewski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004293310","display_name":"Bo\u017cena Sobkowicz","orcid":"https://orcid.org/0000-0002-3297-3320","observed_orcids":["https://orcid.org/0000-0002-3297-3320"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Sobkowicz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003565227","display_name":"S\u0142awomir Dobrzycki","orcid":"https://orcid.org/0000-0003-0599-7017","observed_orcids":["https://orcid.org/0000-0003-0599-7017"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Dobrzycki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024072351","display_name":"Sebastian M. Stec","orcid":"https://orcid.org/0000-0002-9862-318X","observed_orcids":["https://orcid.org/0000-0002-9862-318X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Stec","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5046433162","display_name":"Izabela Wojtkowska","orcid":"https://orcid.org/0000-0002-0951-2139","observed_orcids":["https://orcid.org/0000-0002-0951-2139"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I Wojtkowska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1889,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.58202093,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"50","issue":null,"first_page":"339","last_page":"42"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.024900000542402267,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.008899999782443047,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rofecoxib","display_name":"rofecoxib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.9539999961853027},{"id":"https://openalex.org/keywords/non-st-elevation-myocardial-infarction","display_name":"non-ST-elevation myocardial infarction","score":0.8029999732971191},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":0.871999979019165},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.6650000214576721},{"id":"https://openalex.org/keywords/prostacyclin-synthesis","display_name":"prostacyclin synthesis","score":0.7919999957084656},{"id":"https://openalex.org/keywords/6-keto-pgf1alpha","display_name":"6-keto-PGF1 alpha","score":0.8370000123977661},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.8790000081062317},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.8690000176429749},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.5820000171661377}],"concepts":[{"id":"https://openalex.org/C2778582115","wikidata":"https://www.wikidata.org/wiki/Q411412","display_name":"Rofecoxib","level":4,"score":0.988072395324707},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.8510906100273132},{"id":"https://openalex.org/C2781128415","wikidata":"https://www.wikidata.org/wiki/Q412050","display_name":"Prostacyclin","level":2,"score":0.8485437035560608},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8172084093093872},{"id":"https://openalex.org/C2777698277","wikidata":"https://www.wikidata.org/wiki/Q266018","display_name":"Acute coronary syndrome","level":3,"score":0.5868683457374573},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5613094568252563},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.5589531660079956},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.48526903986930847},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4735875725746155},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34553995728492737},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.3009359538555145},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.15379899740219116},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.07669302821159363},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06273403763771057},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002097","descriptor_name":"C-Reactive Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011464","descriptor_name":"Epoprostenol","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013577","descriptor_name":"Syndrome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015121","descriptor_name":"6-Ketoprostaglandin F1 alpha","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018836","descriptor_name":"Inflammation Mediators","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:16358997","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16358997","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.328.8797","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.328.8797","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.advms.pl/roczniki_2005/volumes/63_Kuklinska_AM_Low dose rofecoxib.pdf","raw_type":"text"},{"id":"mag:2182663471","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16358997","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1963621262","https://openalex.org/W1995528018","https://openalex.org/W2004916700","https://openalex.org/W2023980856","https://openalex.org/W2029998574","https://openalex.org/W2033253411","https://openalex.org/W2050199426","https://openalex.org/W2053230224","https://openalex.org/W2063841251","https://openalex.org/W2076633296","https://openalex.org/W2084120431","https://openalex.org/W2097966917","https://openalex.org/W2123578563","https://openalex.org/W2151091652","https://openalex.org/W2159087408","https://openalex.org/W2172253009","https://openalex.org/W2330496155"],"related_works":["https://openalex.org/W2097966917","https://openalex.org/W2065362788","https://openalex.org/W7096122619","https://openalex.org/W2136952749","https://openalex.org/W2367667402","https://openalex.org/W2069561072","https://openalex.org/W2030462217","https://openalex.org/W2428728632","https://openalex.org/W2329478590","https://openalex.org/W2348671041"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"assess":[2],"the":[3],"influence":[4],"of":[5,51,57,75,82,137,154],"low":[6,46],"dose":[7,47,136],"rofecoxib":[8,76],"on":[9,66,106],"inflammatory":[10],"mediators":[11],"and":[12,60,68,145],"prostacyclin":[13,58],"synthesis":[14,150],"in":[15,22,103,123,151],"patients":[16,32,155],"with":[17,33,45,77,156],"acute":[18],"coronary":[19],"syndromes":[20],"(ACS)":[21],"a":[23,104],"short-term":[24],"follow":[25,71,132],"up.":[26,72,133],"MATERIAL":[27],"AND":[28],"METHODS:":[29],"Twenty":[30],"nine":[31],"ACS":[34],"without":[35],"ST":[36],"elevation":[37],"were":[38,64],"randomized":[39],"to":[40],"simvastatin":[41],"alone":[42,108],"or":[43],"together":[44],"rofecoxib.":[48],"Serum":[49],"levels":[50,81],"interleukin":[52],"6":[53],"(IL-6),":[54],"6-keto-PGF-1alpha--stable":[55],"product":[56],"(PGT2)":[59],"hs-C-reactive":[61],"protein":[62],"(hs-CRP)":[63],"assessed":[65],"enrollment":[67],"after":[69,84],"30-day":[70],"RESULTS:":[73],"Combination":[74],"statin":[78,107],"significantly":[79,122],"decreased":[80],"hs-CRP":[83],"one":[85],"month":[86],"therapy":[87],"(5.21":[88],"mg/l":[89,94,110,115],"+/-":[90,95,111,116],"4.12":[91],"vs":[92,113],"2.11":[93],"2.1;":[96],"p=0.0092).":[97],"This":[98],"effect":[99,144],"was":[100],"not":[101,121,129,147],"evident":[102],"group":[105,153],"(3.95":[109],"3.33":[112],"2.48":[114],"2.39;":[117],"p=0.31).":[118],"6-keto-PGF-1alpha":[119],"increased":[120],"both":[124],"groups.":[125],"IL-6":[126],"concentration":[127],"has":[128],"changed":[130],"during":[131],"CONCLUSIONS:":[134],"Low":[135],"selective":[138],"COX-2":[139],"inhibitor":[140],"exerts":[141],"significant":[142],"anti-inflammatory":[143],"does":[146],"diminish":[148],"PG12":[149],"study":[152],"ACS.":[157]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}